CVS Health's Insider Buying and Dividend Yields Attract Investors
PorAinvest
martes, 8 de julio de 2025, 4:57 pm ET1 min de lectura
CVS--
The dividend represents a 3.99% yield, making it an attractive option for income-focused investors. CVS Health's dividend payout ratio of 63.48% indicates that its dividend is sufficiently covered by earnings [2]. Research analysts expect the company to earn $6.77 per share next year, with an expected future payout ratio of 39.3% [1].
Director Guy P. Sansone's recent purchase of 1,570 shares at $63.70 per share, totaling $100,090, signals insider confidence in the company's prospects. The transaction, disclosed in a legal filing with the Securities & Exchange Commission, represents a 15.04% increase in the director's position [1].
CVS Health's stock has a market cap of $84.18 billion, a P/E ratio of 15.89, and a price-to-earnings-growth ratio of 0.97. The company's stock has a 52-week low of $43.56 and a 52-week high of $72.51. Analysts have rated the stock with a consensus rating of "Moderate Buy" and a consensus price target of $75.06 [1].
The company's strong quarterly dividend history, favorable long-term growth rates, and insider buying make CVS Health an attractive value and profitability stock for investors. However, as with any investment, it is essential to conduct thorough research and consider your financial goals and risk tolerance before making any investment decisions.
References:
[1] https://www.marketbeat.com/instant-alerts/cvs-health-corporation-nysecvs-to-issue-quarterly-dividend-of-067-2025-07-07/
[2] https://www.marketscreener.com/quote/stock/CVS-HEALTH-CORPORATION-12230/news/Cvs-Health-Announces-A-Quarterly-Dividend-Payable-on-August-1-2025-50448582/
CVS Health Corporation has been named a top dividend stock with insider buying and a 3.99% yield. Director Guy P. Sansone recently invested $100,009 in 1,570 shares at $63.70 per share. The company has a strong quarterly dividend history and favorable long-term growth rates, making it an attractive value and profitability stock for investors.
CVS Health Corporation (NYSE: CVS), a leading pharmacy operator and healthcare services provider, has been recognized as a top dividend stock due to its strong quarterly dividend history and favorable long-term growth rates. The company recently announced a quarterly dividend of $0.665 per share, payable on August 1, 2025, to shareholders of record on July 22, 2025 [1].The dividend represents a 3.99% yield, making it an attractive option for income-focused investors. CVS Health's dividend payout ratio of 63.48% indicates that its dividend is sufficiently covered by earnings [2]. Research analysts expect the company to earn $6.77 per share next year, with an expected future payout ratio of 39.3% [1].
Director Guy P. Sansone's recent purchase of 1,570 shares at $63.70 per share, totaling $100,090, signals insider confidence in the company's prospects. The transaction, disclosed in a legal filing with the Securities & Exchange Commission, represents a 15.04% increase in the director's position [1].
CVS Health's stock has a market cap of $84.18 billion, a P/E ratio of 15.89, and a price-to-earnings-growth ratio of 0.97. The company's stock has a 52-week low of $43.56 and a 52-week high of $72.51. Analysts have rated the stock with a consensus rating of "Moderate Buy" and a consensus price target of $75.06 [1].
The company's strong quarterly dividend history, favorable long-term growth rates, and insider buying make CVS Health an attractive value and profitability stock for investors. However, as with any investment, it is essential to conduct thorough research and consider your financial goals and risk tolerance before making any investment decisions.
References:
[1] https://www.marketbeat.com/instant-alerts/cvs-health-corporation-nysecvs-to-issue-quarterly-dividend-of-067-2025-07-07/
[2] https://www.marketscreener.com/quote/stock/CVS-HEALTH-CORPORATION-12230/news/Cvs-Health-Announces-A-Quarterly-Dividend-Payable-on-August-1-2025-50448582/
Divulgación editorial y transparencia de la IA: Ainvest News utiliza tecnología avanzada de Modelos de Lenguaje Largo (LLM) para sintetizar y analizar datos de mercado en tiempo real. Para garantizar los más altos estándares de integridad, cada artículo se somete a un riguroso proceso de verificación con participación humana.
Mientras la IA asiste en el procesamiento de datos y la redacción inicial, un miembro editorial profesional de Ainvest revisa, verifica y aprueba de forma independiente todo el contenido para garantizar su precisión y cumplimiento con los estándares editoriales de Ainvest Fintech Inc. Esta supervisión humana está diseñada para mitigar las alucinaciones de la IA y garantizar el contexto financiero.
Advertencia sobre inversiones: Este contenido se proporciona únicamente con fines informativos y no constituye asesoramiento profesional de inversión, legal o financiero. Los mercados conllevan riesgos inherentes. Se recomienda a los usuarios que realicen una investigación independiente o consulten a un asesor financiero certificado antes de tomar cualquier decisión. Ainvest Fintech Inc. se exime de toda responsabilidad por las acciones tomadas con base en esta información. ¿Encontró un error? Reportar un problema

Comentarios
Aún no hay comentarios